Enhancing Diagnostic Accuracy in Colon Cancer Patients with Fluorouracil Implants

Strategic Insights -

Researchers at the Department of Radiology, Taikang Tongji (Wuhan) Hospital, have made significant contributions to the field of oncology by investigating the diagnostic accuracy of radiologists in assessing gastric and colorectal cancer patients with fluorouracil implants. The study, published in the journal Quantitative Imaging in Medicine and Surgery, aimed to enhance the diagnostic accuracy of radiologists by providing them with training on implant imaging characteristics and precise surgical record documentation.

Key Takeaways:

  • The study involved a retrospective analysis of 240 computed tomography (CT) examinations of patients with fluorouracil implants, which were randomly selected from a total of 164 patients.
  • The radiologists assessed the implant-related tumor-like lesions in three stages: stage 1 (pre-training without surgical information), stage 2 (post-training without surgical information), and stage 3 (post-training with surgical details provided).
  • The diagnostic accuracy and confidence of the radiologists improved in stage 2 compared to stage 1, with accuracy increasing from 67.5% to 91.25% and confidence rating increasing from low to medium.
  • The imaging features that differentiated between fluorouracil implant-related lesions and malignant lesions included a typical foreign body reaction (85.71%), no contrast enhancement on CT/magnetic resonance imaging, and no diffusion restriction on diffusion-weighted imaging.
  • Follow-up CT scans showed a size reduction in 67.26% of the lesions and density changes in 52.98%.
  • The study concluded that providing radiologists with training on implant imaging characteristics and precise surgical record documentation can improve diagnostic accuracy and confidence.

Statistics:

  • 240 CT examinations were randomly selected from all available CT examinations of patients with fluorouracil implants.
  • 164 patients had confirmed fluorouracil implants in the subdiaphragmatic regions, paracolic gutters, and tumor beds.
  • 85.71% of the lesions had a typical foreign body reaction.
  • 67.26% of the lesions showed a size reduction in follow-up CT scans.
  • 52.98% of the lesions showed density changes in follow-up CT scans.
  • The diagnostic accuracy of radiologists improved from 67.5% to 91.25% in stage 2 compared to stage 1.
  • The confidence rating of radiologists increased from low to medium in stage 2 compared to stage 1.

Sources:

  • "Enhancing postoperative recurrence assessment in gastric and colorectal cancer patients with intraperitoneal fluorouracil implants: overcoming the diagnostic challenge of fluorouracil implant-related tumor-like lesions" (Quantitative Imaging in Medicine and Surgery, 2025;15(9):7774-7787)
  • Xin Chen, et al. "Researchers from Department of Radiology Detail Findings in Colon Cancer (Enhancing postoperative recurrence assessment in gastric and colorectal cancer patients with intraperitoneal fluorouracil implants: overcoming the diagnostic challenge of ...)" (Cancer Weekly, September 16, 2025; p 2951)